Sector
PharmaceuticalsOpen
₹1,131Prev. Close
₹1,126.7Turnover(Lac.)
₹18,740.23Day's High
₹1,172Day's Low
₹1,099.652 Week's High
₹1,309.952 Week's Low
₹701.8Book Value
₹145.27Face Value
₹1Mkt Cap (₹ Cr.)
17,648.85P/E
0EPS
1.54Divi. Yield
0.4512 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
9 Aug 2024
12:00 AM
AGM
Announcement Date: 09 Aug, 2024
The API division posted a turnover of ₹609 Crore for the financial year ended March 2025. This was 8.35% of the company’s consolidated revenue.
Here are some of the stocks that may see significant price movement today: Torrent Power, DCM Shriram, Jubilant Pharmova, etc.
This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.
Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.
Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 15.9 | 15.9 | 15.93 | 15.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,358.6 | 2,398.6 | 2,423.14 | 1,266.52 |
Net Worth | 2,374.5 | 2,414.5 | 2,439.07 | 1,282.45 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 2,709.49 | 3,139.9 | 3,306.32 | 2,491.22 |
yoy growth (%) | -13.7 | -5.03 | 32.71 | -6.2 |
Raw materials | -1,450.36 | -1,684.42 | -1,780.39 | -1,307.02 |
As % of sales | 53.52 | 53.64 | 53.84 | 52.46 |
Employee costs | -220.67 | -264.9 | -264.41 | -226.3 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 273.16 | 300.54 | 367.69 | 114.52 |
Depreciation | -99.97 | -107.39 | -82.59 | -81.12 |
Tax paid | -58.69 | 22.3 | -104.25 | -35.32 |
Working capital | -964.78 | 534.81 | -82.75 | -63.88 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -13.7 | -5.03 | 32.71 | -6.2 |
Op profit growth | 15.13 | -31.21 | 69.57 | 1.83 |
EBIT growth | -14.14 | -13.15 | 74.13 | 0.6 |
Net profit growth | -33.21 | 21.9 | 232.65 | 8.48 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 7,192.1 | 6,644.8 | 6,219.3 | 6,059.17 | 5,963.88 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 7,192.1 | 6,644.8 | 6,219.3 | 6,059.17 | 5,963.88 |
Other Operating Income | 42.4 | 58.1 | 62.4 | 70.99 | 134.66 |
Other Income | 416.3 | 92.8 | 50.6 | 11.29 | 290.64 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Shyam S Bhartia
Co-Chairman & Non-Exe.Director
Hari S Bhartia
Non-Exec. & Independent Dir.
Vivek Mehra
Non-Exec. & Independent Dir.
SUSHIL KUMAR ROONGTA
Managing Director
Priyavrat Bhartia
Joint Managing Director
Arjun Shanker Bhartia
Non-Exec. & Independent Dir.
Arun Seth
Whole Time Director & CFO
Arvind Chokhany
Company Sec. & Compli. Officer
Naresh Kapoor
Independent Director
Shirish Gundopant Belapure
Whole-time Director
Ramakrishnan Arul
Independent Director
Harsh Mahajan
Independent Director
Shivpriya Nanda
Bhartiagram Gajraula,
Uttar Pradesh - 244223
Tel: 91-5924-267200
Website: http://www.jubl.com
Email: investors@jubl.com
Alankit Heights,
1E/13 Jhandewalan Ex,
New Delhi-110055
Tel: 91-11-42541234
Website: www.alankit.com
Email: rta@alankit.com
Summary
Jubilant Pharmova Limited was initially incorporated as Vam Organic Chemicals Limited on June 21, 1978. The Company name was thereafter changed to Jubliant Organosys Limited in November, 2001 and to J...
Read More
Reports by Jubilant Pharmova Ltd
What is the Jubilant Pharmova Ltd share price today?
What is the Market Cap of Jubilant Pharmova Ltd?
What is the PE and PB ratio of Jubilant Pharmova Ltd?
What is the 52 Week High and Low of Jubilant Pharmova Ltd?
What is the CAGR of Jubilant Pharmova Ltd?
What is the shareholding pattern of Jubilant Pharmova Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
